Lv4
550 积分 2021-08-12 加入
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2天前
已完结
The MG‐QOL15 for following the health‐related quality of life of patients with myasthenia gravis
1个月前
已完结
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
1个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
2个月前
已完结
The immunology of systemic lupus erythematosus
2个月前
已完结
CAR T-cell therapy in autoimmune diseases
2个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2个月前
已完结
Gastric cancer
2个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
3个月前
已完结
皖公网安备34019202002308
